Stay updated on Testing KRT-232 Combo with Decitabine & Venetoclax in AML Clinical Trial
Sign up to get notified when there's something new on the Testing KRT-232 Combo with Decitabine & Venetoclax in AML Clinical Trial page.

Latest updates to the Testing KRT-232 Combo with Decitabine & Venetoclax in AML Clinical Trial page
- Check7 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1.SummaryDifference0.1%
- Check14 days agoChange DetectedThe web page has been updated to include new therapeutic information and specific drug details related to acute myeloid leukemia, while removing outdated references to certain diseases and treatment agents.SummaryDifference3%
- Check21 days agoChange DetectedThe webpage has updated its last update date to reflect more recent information, moving from July 2025 to August 2025. Additionally, previous update dates have been removed, indicating a shift in the timeline of content updates.SummaryDifference0.9%
- Check29 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.5%
- Check36 days agoChange DetectedThe web page has been updated from version 2.16.10 to version 2.16.11.SummaryDifference0.1%
- Check43 days agoChange DetectedThe page has updated its revision number to v2.16.10 and now references the VCU Massey Comprehensive Cancer Center instead of the previous name. Additionally, the planned maintenance notice has been removed.SummaryDifference1%
Stay in the know with updates to Testing KRT-232 Combo with Decitabine & Venetoclax in AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Testing KRT-232 Combo with Decitabine & Venetoclax in AML Clinical Trial page.